[Rare pancreatic tumors].

Seltene Pankreastumoren.
Acinar cell carcinoma Differential diagnosis Molecular pathology Pancreatoblastoma Solid pseudopapillary neoplasm

Journal

Der Pathologe
ISSN: 1432-1963
Titre abrégé: Pathologe
Pays: Germany
ID NLM: 8006541

Informations de publication

Date de publication:
Sep 2021
Historique:
accepted: 06 07 2021
pubmed: 18 8 2021
medline: 1 9 2021
entrez: 17 8 2021
Statut: ppublish

Résumé

Beyond pancreatic ductal adenocarcinoma, which is by far the most frequent pancreatic neoplasm, a great variety of tumors occur in the pancreas. They include solid and cystic masses and epithelial and nonepithelial neoplasms, and they show a great diversity in their biological behavior, ranging from benign tumors to highly aggressive neoplasms. As examples of rare pancreatic tumors, clinical, morphological, and molecular aspects of acinar cell carcinoma, pancreatoblastoma, solid pseudopapillary neoplasm, and serous cystic neoplasms are presented and discussed. Neben dem weitaus häufigsten Pankreastumor, dem duktalen Adenokarzinom des Pankreas, existieren zahlreiche solide und zystische, epitheliale und nichtepitheliale Tumoren im Pankreas, die für sich genommen jeweils selten sind und klinisch ein breites Spektrum von benignen Tumoren bis zu hochaggressiven, metastasierungs- und rezidivfreudigen Neoplasien abdecken. Exemplarisch werden in der vorliegenden Übersicht klinische, morphologische und molekulare Kriterien von Azinuszellkarzinomen, Pankreatoblastomen, solid-pseudopapillären Neoplasien und serös-zystischen Neoplasien vorgestellt, anhand derer eine differenzialdiagnostische Einordnung in der Regel leicht möglich ist.

Autres résumés

Type: Publisher (ger)
Neben dem weitaus häufigsten Pankreastumor, dem duktalen Adenokarzinom des Pankreas, existieren zahlreiche solide und zystische, epitheliale und nichtepitheliale Tumoren im Pankreas, die für sich genommen jeweils selten sind und klinisch ein breites Spektrum von benignen Tumoren bis zu hochaggressiven, metastasierungs- und rezidivfreudigen Neoplasien abdecken. Exemplarisch werden in der vorliegenden Übersicht klinische, morphologische und molekulare Kriterien von Azinuszellkarzinomen, Pankreatoblastomen, solid-pseudopapillären Neoplasien und serös-zystischen Neoplasien vorgestellt, anhand derer eine differenzialdiagnostische Einordnung in der Regel leicht möglich ist.

Identifiants

pubmed: 34402979
doi: 10.1007/s00292-021-00967-0
pii: 10.1007/s00292-021-00967-0
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

484-490

Informations de copyright

© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Références

Abdallah MA, Ahmed K, Taha W et al (2021) Endoscopic ultrasound guided fine-needle aspiration for solid lesions in chronic pancreatitis: A systematic review and meta-analysis. Dig Dis Sci. https://doi.org/10.1007/s10620-021-07066-3
doi: 10.1007/s10620-021-07066-3 pubmed: 34086166
Abraham SC, Klimstra DS, Wilentz RE et al (2002) Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 160:1361–1369
pubmed: 11943721 pmcid: 1867216 doi: 10.1016/S0002-9440(10)62563-1
Abraham SC, Wu TT, Klimstra DS et al (2001) Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 159:1619–1627
pubmed: 11696422 pmcid: 1867075 doi: 10.1016/S0002-9440(10)63008-8
Amato E, Mafficini A, Hirabayashi K et al (2019) Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas. J Pathol 247:123–134
pubmed: 30306561 doi: 10.1002/path.5180
Askan G, Deshpande V, Klimstra DS et al (2016) Expression of markers of hepatocellular differentiation in pancreatic Acinar cell neoplasms: a potential diagnostic pitfall. Am J Clin Pathol 146:163–169
pubmed: 27425386 pmcid: 5731433 doi: 10.1093/ajcp/aqw096
Bergmann F, Andrulis M, Hartwig W et al (2011) Discovered on gastrointestinal stromal tumor 1 (DOG1) is expressed in pancreatic centroacinar cells and in solid-pseudopapillary neoplasms—novel evidence for a histogenetic relationship. Hum Pathol 42:817–823
pubmed: 21295818 doi: 10.1016/j.humpath.2010.10.005
Bergmann F, Aulmann S, Sipos B et al (2014) Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases. Virchows Arch 465:661–672
pubmed: 25298229 doi: 10.1007/s00428-014-1657-8
Bergmann F, Aulmann S, Welsch T et al (2014) Molecular analysis of pancreatic acinar cell cystadenomas: evidence of a non-neoplastic nature. Oncol Lett 8:852–858
pubmed: 25009661 pmcid: 4081433 doi: 10.3892/ol.2014.2163
Cao D, Antonescu C, Wong G et al (2006) Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations. Mod Pathol 19:1157–1163
pubmed: 16778826 doi: 10.1038/modpathol.3800647
Cavallini A, Falconi M, Bortesi L et al (2009) Pancreatoblastoma in adults: a review of the literature. Pancreatology 9:73–80
pubmed: 19077457 doi: 10.1159/000178877
Cingolani N, Shaco-Levy R, Farruggio A et al (2000) Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma. Hum Pathol 31:938–944
pubmed: 10987254 doi: 10.1053/hupa.2000.9075
Colombo P, Arizzi C, Roncalli M (2004) Acinar cell cystadenocarcinoma of the pancreas: report of rare case and review of the literature. Hum Pathol 35:1568–1571
pubmed: 15619219 doi: 10.1016/j.humpath.2004.08.004
Crinò SF, Di Mitri R, Nguyen NQ et al (2021) EUS-guided fine-needle biopsy with or without rapid on-site evaluation for diagnosis of solid pancreatic lesions: A randomized controlled non-inferiority trial. Gastroenterology. https://doi.org/10.1053/j.gastro.2021.06.005
doi: 10.1053/j.gastro.2021.06.005 pubmed: 34116031
Defachelles AS, De Lassalle ME, Boutard P et al (2001) Pancreatoblastoma in childhood: clinical course and therapeutic management of seven patients. Med Pediatr Oncol 37:47–52
pubmed: 11466723 doi: 10.1002/mpo.1162
Dhebri AR, Connor S, Campbell F et al (2004) Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology 4:441–451 (discussion 452–443)
pubmed: 15256806 doi: 10.1159/000079823
Drut R, Jones MC (1988) Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association. Pediatr Pathol 8:331–339
pubmed: 2845376 doi: 10.3109/15513818809042976
Estrella JS, Li L, Rashid A et al (2014) Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. Am J Surg Pathol 38:147–157
pubmed: 24418850 doi: 10.1097/PAS.0000000000000141
Furlan D, Sahnane N, Bernasconi B et al (2014) APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation. Virchows Arch 464:553–564
pubmed: 24590585 doi: 10.1007/s00428-014-1562-1
Jais B, Rebours V, Malleo G et al (2016) Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut 65:305–312
pubmed: 26045140 doi: 10.1136/gutjnl-2015-309638
Jakel C, Bergmann F, Toth R et al (2017) Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability. Nat Commun 8:1323
pubmed: 29109526 pmcid: 5673892 doi: 10.1038/s41467-017-01118-x
Jiao Y, Yonescu R, Offerhaus GJ et al (2014) Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 232:428–435
pubmed: 24293293 pmcid: 4048021 doi: 10.1002/path.4310
Kang CM, Choi SH, Kim SC et al (2014) Predicting recurrence of pancreatic solid pseudopapillary tumors after surgical resection: a multicenter analysis in Korea. Ann Surg 260:348–355
pubmed: 24743622 doi: 10.1097/SLA.0000000000000583
Kerr NJ, Chun YH, Yun K et al (2002) Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression. Med Pediatr Oncol 39:52–54
pubmed: 12116082 doi: 10.1002/mpo.10050
Kim SG, Wu TT, Lee JH et al (2003) Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Pathol 16:1086–1094
pubmed: 14614047 doi: 10.1097/01.MP.0000094088.37888.A6
Klimstra DS (2007) Nonductal neoplasms of the pancreas. Mod Pathol 20(Suppl 1):S94–S112
pubmed: 17486055 doi: 10.1038/modpathol.3800686
Klimstra DS, Heffess CS, Oertel JE et al (1992) Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 16:815–837
pubmed: 1384374 doi: 10.1097/00000478-199209000-00001
Kloppel G, Morohoshi T, John HD et al (1981) Solid and cystic acinar cell tumour of the pancreas. A tumour in young women with favourable prognosis. Virchows Arch A Pathol Anat Histol 392:171–183
pubmed: 7281507 doi: 10.1007/BF00430819
Koh TH, Cooper JE, Newman CL et al (1986) Pancreatoblastoma in a neonate with Wiedemann-Beckwith syndrome. Eur J Pediatr 145:435–438
pubmed: 3792392 doi: 10.1007/BF00439255
Kominami A, Fujino M, Murakami H et al (2014) Beta-catenin mutation in ovarian solid pseudopapillary neoplasm. Pathol Int 64:460–464
pubmed: 25186079 doi: 10.1111/pin.12194
Kosmahl M, Pauser U, Peters K et al (2004) Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 445:168–178
pubmed: 15185076 doi: 10.1007/s00428-004-1043-z
Kosmahl M, Wagner J, Peters K et al (2004) Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 28:339–346
pubmed: 15104296 doi: 10.1097/00000478-200403000-00006
La Rosa S, Adsay V, Albarello L et al (2012) Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers. Am J Surg Pathol 36:1782–1795
pubmed: 23026929 doi: 10.1097/PAS.0b013e318263209d
La Rosa S, Franzi F, Marchet S et al (2009) The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch 454:133–142
pubmed: 19066953 doi: 10.1007/s00428-008-0710-x
Law JK, Ahmed A, Singh VK et al (2014) A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas 43:331–337
pubmed: 24622060 pmcid: 4888067 doi: 10.1097/MPA.0000000000000061
Martin RC, Klimstra DS, Brennan MF et al (2002) Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol 9:35–40
pubmed: 11833495 doi: 10.1245/aso.2002.9.1.35
Mccluney S, Wijesuriya N, Sheshappanavar V et al (2018) Solid pseudopapillary tumour of the pancreas: clinicopathological analysis. ANZ J Surg 88:891–895
pubmed: 29316119 doi: 10.1111/ans.14362
Michalova K, Michal M, Sedivcova M et al (2018) Solid pseudopapillary neoplasm (SPN) of the testis: comprehensive mutational analysis of 6 testicular and 8 pancreatic SPNs. Ann Diagn Pathol 35:42–47
pubmed: 29705715 doi: 10.1016/j.anndiagpath.2018.04.003
Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188
doi: 10.1111/his.13975
Nguyen NQ, Johns AL, Gill AJ et al (2011) Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. J Gastroenterol Hepatol 26:267–274
pubmed: 21261715 doi: 10.1111/j.1440-1746.2010.06466.x
Papavramidis T, Papavramidis S (2005) Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. J Am Coll Surg 200:965–972
pubmed: 15922212 doi: 10.1016/j.jamcollsurg.2005.02.011
Potts SR, Brown S, O’hara MD (1986) Pancreatoblastoma in a neonate associated with Beckwith-Wiedemann syndrome. Z Kinderchir 41:56–57
pubmed: 3962517
Slukvin I, Hafez GR, Niederhuber JE et al (2003) Combined serous microcystic adenoma and well-differentiated endocrine pancreatic neoplasm: a case report and review of the literature. Arch Pathol Lab Med 127:1369–1372
pubmed: 14521452 doi: 10.5858/2003-127-1369-CSMAAW
Tanaka Y, Kato K, Notohara K et al (2001) Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 61:8401–8404
pubmed: 11731417
Tanaka Y, Notohara K, Kato K et al (2002) Usefulness of beta-catenin immunostaining for the differential diagnosis of solid-pseudopapillary neoplasm of the pancreas. Am J Surg Pathol 26:818–820
pubmed: 12023593 doi: 10.1097/00000478-200206000-00023
Tang LH, Aydin H, Brennan MF et al (2005) Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol 29:512–519
pubmed: 15767807 doi: 10.1097/01.pas.0000155159.28530.88
Terris B, Cavard C (2014) Diagnosis and molecular aspects of solid-pseudopapillary neoplasms of the pancreas. Semin Diagn Pathol 31:484–490
pubmed: 25524568 doi: 10.1053/j.semdp.2014.08.010
Toll AD, Mitchell D, Yeo CJ et al (2011) Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature. Int J Surg Pathol 19:795–799
pubmed: 19584100 doi: 10.1177/1066896909339912
Wood LD, Klimstra DS (2014) Pathology and genetics of pancreatic neoplasms with acinar differentiation. Semin Diagn Pathol 31:491–497
pubmed: 25441307 pmcid: 4316670 doi: 10.1053/j.semdp.2014.08.003

Auteurs

M Hämmerle (M)

Institut für Pathologie, Universitätsklinikum Halle, Halle, Deutschland.

F Bergmann (F)

MVZ für Klinische Pathologie, Klinikum Darmstadt, Grafenstraße 9, 64283, Darmstadt, Deutschland. frank.bergmann@mail.klinikum-darmstadt.de.
Institut für Pathologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland. frank.bergmann@mail.klinikum-darmstadt.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH